178 related articles for article (PubMed ID: 11508855)
61. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
62. Identification of genes induced by BRCA1 in breast cancer cells.
Atalay A; Crook T; Ozturk M; Yulug IG
Biochem Biophys Res Commun; 2002 Dec; 299(5):839-46. PubMed ID: 12470655
[TBL] [Abstract][Full Text] [Related]
63. BRCA1 is differentially expressed in human tumor cells.
Meng QH; Yuan RQ; Goldberg ID; Rosen EM; Fan SJ
Shi Yan Sheng Wu Xue Bao; 2001 Mar; 34(1):55-64. PubMed ID: 12549011
[TBL] [Abstract][Full Text] [Related]
64. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
65. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
Antonova L; Mueller CR
Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
[TBL] [Abstract][Full Text] [Related]
66. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
67. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
68. Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
Andres SA; Wittliff JL
Endocrine; 2011 Oct; 40(2):212-21. PubMed ID: 21858728
[TBL] [Abstract][Full Text] [Related]
69. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Williamson EA; Dadmanesh F; Koeffler HP
Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
[TBL] [Abstract][Full Text] [Related]
70. PML protein expression in hereditary and sporadic breast cancer.
Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
[TBL] [Abstract][Full Text] [Related]
71. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
72. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.
Saelee P; Chaiwerawattana A; Ogawa K; Cho YM; Tiwawech D; Suktangman V
Asian Pac J Cancer Prev; 2014; 15(24):10585-9. PubMed ID: 25605143
[TBL] [Abstract][Full Text] [Related]
74. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
75. Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis.
Triano EA; Slusher LB; Atkins TA; Beneski JT; Gestl SA; Zolfaghari R; Polavarapu R; Frauenhoffer E; Weisz J
Cancer Res; 2003 Jun; 63(12):3092-100. PubMed ID: 12810634
[TBL] [Abstract][Full Text] [Related]
76. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
77. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
78. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
79. Down-regulation of CYP1A1 expression in breast cancer.
Hafeez S; Ahmed A; Rashid AZ; Kayani MA
Asian Pac J Cancer Prev; 2012; 13(5):1757-60. PubMed ID: 22901117
[TBL] [Abstract][Full Text] [Related]
80. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
